Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Current Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

IGC Pharma (IGC) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Pharma (IGC) over the last 14 years, with Q3 2025 value amounting to $25000.0.

Pharma's Long-Term Investments changed N/A to $25000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $25000.0, marking a year-over-year change of. This contributed to the annual value of $12000.0 for FY2021, which is 909.09% up from last year.
Pharma's Long-Term Investments amounted to $25000.0 in Q3 2025.
In the past 5 years, Pharma's Long-Term Investments registered a high of $25000.0 during Q3 2025, and its lowest value of $11000.0 during Q2 2021.